TABLE 3.

The role of novel polymeric nanoagents in cancer theranostics.

Types	Conjugation	Theranostics	Indications	Advantages	Ref
Cy@Silk	Tc	SPECT and real-timely monitoring	Various cancers	Visualizing the distribution of nanoagents, real-timely monitoring cancer progression and maximizing the therapeutic efficacy	Wang et al. (2019a)
SPNs	Peroxidase	NIR-II-based PA and PTT	Various cancers	Elevating the sensitivity of diagnosis and the efficacy of PTT with the stronger PA signals	Lyu et al. (2018)
SPNs	—	NIR-II-based PA and PTT	Gliomas	Augmenting the absorption and inducing cancer cells death in both shallow and deep tissues	Wen et al. (2020)
AIE	ApoE	NIR-II-based PTT	GBM	Showing a higher PTT efficiency	Wang et al. (2022a)